Growth of the normal skull vault and its alteration in craniosynostosis: Insights from human genetics and experimental studies

Journal of Anatomy

Volumn 207, Issue 5, 2005, Pages 637-653

  Morriss Kay, Gillian M ^a   Wilkie, Andrew O M ^b  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Cranial sutures; Efnbl; Fibroblast growth factor receptors; Msx2; Neural crest; Osteoprogenitor cells; Twist1

Indexed keywords

FIBROBLAST GROWTH FACTOR RECEPTOR 1; FIBROBLAST GROWTH FACTOR RECEPTOR 2; FIBROBLAST GROWTH FACTOR RECEPTOR 3; GENE PRODUCT; PROTEIN EFNB1; TRANSCRIPTION FACTOR MSX2; TRANSCRIPTION FACTOR TWIST; TRANSCRIPTION FACTOR TWIST1; UNCLASSIFIED DRUG;

BONE GROWTH; BONE MATRIX; BRAIN GROWTH; CELL DIFFERENTIATION; CELL POPULATION; CELL PROLIFERATION; CRANIOFACIAL SYNOSTOSIS; GENE MUTATION; GENETICS; HUMAN; MAMMAL; MESODERM; MOUSE MUTANT; NEURAL CREST; NONHUMAN; OSTEOBLAST; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; SKULL DEVELOPMENT; STEM CELL; SYNOSTOSIS; TISSUE INTERACTION;

MAMMALIA;

EID: 28444453646     PISSN: 00218782     EISSN: 14697580     Source Type: Journal    
DOI: 10.1111/j.1469-7580.2005.00475.x     Document Type: Review

References (96)

1. Anderson J, Burns HD, Enriquez-Harris P, Wilkie AOM, Heath JK (1998) Apert syndrome mutations in fibroblast growth factor receptor 2 exhibit increased affinity for FGF ligand. Hum Mol Genet 7, 1475-1483.
2. Arman E, Haffner-Krausz R, Chen Y, Heath JK, Lonai P (1998) Targeted disruption of FGFR2 suggests a role for FGF signalling in pre-gastrulation mammalian development. Proc Natl Acad Sci USA 95, 5082-5087.
3. Beer HD, Vindevoghel L, Gait MJ, et al. (2000) Fibroblast growth factor (FGF) receptor 1-IIIb is a naturally occurring functional receptor for FGfs that is preferentially expressed in the skin and brain. J Biol Chem 275, 16091-16097.
4. Beiman M, Shilo BZ, Volk T (1996) Heartless, a Drosophila FGF receptor homolog, is essential for cell migration and establishment of several mesodermal lineages. Genes Dev 10, 2993-3002.
5. Bellus GA, Gaudenz K, Zackai EH, et al. (1996) Identical mutations in three different fibroblast growth factor receptor genes in autosomal dominant craniosynostosis syndromes. Nature Genet 14, 174-176.
6. Bennett VR, Brown LK (1999) Myles Textbook for Midwives. Edinburgh: Churchill Livingstone.
7. Bialek P, Kern B, Yang X, et al. (2004) A Twist code determines the onset of osteoblast differentiation. Dev Cell 6, 423-435.
8. Bourgeois P, Bolcato-Bellemin AL, Danse JM, et al. (1998) The variable expressivity and incomplete penetrance of the twistnull heterozygous mouse phenotype resemble those of human Saethre-Chotzen syndrome. Hum Mol Genet 7, 945-957.
9. Bradley JP, Levine JP, Roth DA, McCarthy JG, Longaker MT (1996) Studies in cranial suture biology. IV. Temporal sequence of posterior frontal cranial suture fusion in the mouse. Plast Reconstr Surg 98, 1039-1045.
10. Carver EA, Oram KF, Gridley T (2002) Craniosynostosis in Twist heterozygous mice: a model for Saethre-Chotzen syndrome. Anat Rec 268, 90-92.
11. Chai Y, Jiang X, Ito Y, Bringas P Jr, Han J, Rowitch DH, Soriano P, McMahon AP, Sucov HM (2000) Fate of the mammalian cranial neural crest during tooth and mandibular morphogenesis. Development 127, 1671-1679.
12. Chan WY, Tam PPL (1988) A morphological and experimental study of the mesencephalic neural crest cells in the mouse embryo using wheat germ agglutinin-gold conjugate as the cell marker. Development 102, 427-442.
13. Chen L, Li D, Li C, Engl A, Deng CX (2003) A Series 250Trp substitution in mouse fibroblast growth factor receptor 2 (Fgfr2) results in craniosynostosis. Bone 33, 169-178.
14. Chen ZF, Behringer RR (1995) Twist is required in head mesenchyme for cranial neural tube morphogenesis. Genes Dev 9, 686-699.
15. Chong LD, Park EK, Latimer E, Friesel R, Daar IO (2000) Fibroblast growth factor receptor-mediated rescue of x-ephrin B1-induced cell dissociation in Xenopus embryos. Mol Cell Biol 20, 724-734.
16. Cohen MM Jr (1979) Craniofrontonasal dysplasia. Birth Defects 15 (5B), 85-89.
17. Cohen MM Jr (2000) Epidemiology of craniosynostosis. In Craniosynostosis (eds Cohen MM Jr, MacLean RE), 2nd edition, pp. 112-118. New York: Oxford University Press.
18. Colvin JS, Bohne BA, Harding GW, McEwan DG, Ornitz DM (1996) Skeletal overgrowth and deafness in mice lacking fibroblast growth factor receptor 3. Nat Genet 12, 390-397.
19. Compagni A, Logan M, Klein R, Adams RH (2003) Control of skeletal patterning by ephrinB1-EphB interactions. Dev Cell 5, 217-230.
20. Corliss CE (1976) Patten's Human Embryology. New York: McGraw-Hill.
21. Creuzet S, Couly G, Vincent C, le Douarin NM (2002) Negative effect of Hox gene expression on the development of the neural crest-derived facial skeleton. Development 129, 4301-4313.
22. Deng C, Wynshaw-Boris A, Zhou F, Kuo A, Leder P (1996) Fibroblast growth factor receptor 3 is a negative regulator of bone growth. Cell 84, 911-921.
23. El Ghouzzi V, LeMerrer M, Perrin-Schmidt F, et al. (1997) Mutations of the TWIST gene in the Saethre-Chotzen syndrome. Nat Genet 15, 42-46.
24. El Ghouzzi V, Legeai-Mallet L, Benoist-Lasselin C, et al. (2001) Mutations in the basic domain and the loop-helix II junction of TWIST abolish DNA binding in Saethre-Chotzen syndrome. FEBS Lett 492, 112-118.
25. Eswarakumar VP, Monsonego-Ornan E, Pines M, Antonopoulou I, Morriss-Kay GM, Lonai P (2002) The IIIc alternative of Fgfr2 is a positive regulator of bone formation. Development 129, 3783-3793.
26. Eswarakumar VP, Horowitz MC, Locklin R, Morriss-Kay GM, Lonai P (2004) A gain-of-function mutation of Fgfr2c demonstrates the roles of this receptor variant in osteogenesis. Proc Natl Acad Sci USA 101, 12555-12560.
27. Fukiishi Y, Morriss-Kay GM (1992) Migration of cranial neural crest cells to the pharyngeal arches and heart in rat embryos. Cell Tissue Res 268, 1-8.
28. Gorlin RJ, Cohen MM, Hennekam RCM (2001) Syndromes of the Head and Neck, 4th edn. New York: Oxford University Press.
29. Guenou H, Kaabeche K, Le Mée S, Marie PJ (2005) A role for fibroblast growth factor receptor-2 in the altered osteoblast phenotype induced by Twist haploinsufficiency in the Saethre-Chotzen syndrome. Hum Mol Genet 14, 1429-1439.
30. Hajihosseini MK, Wilson S, De Moerlooze L, Dickson C (2001) A splicing switch and gain-of-function mutation in FgfR2-IIIc hemizygotes causes Apert/Pfeiffer syndrome-like phenotypes. Proc Natl Acad Sci USA 98, 3641-3643.
31. Hajihosseini MK, Heath JK (2002) Expression patterns of fibroblast growth factors-18 and -20 in mouse embryos is suggestive of novel roles in calvarial and limb development. Mech Dev 113, 79-83.
32. Hajihosseini MK, Lalioti MD. Arthaud S, Burgar HR, Brown JM, Twigg SR, Wilkie AO, Heath JK (2004) Skeletal development is regulated by fibroblast growth factor receptor 1 signalling dynamics. Development 131, 325-335.
33. Henderson JH, Longaker MT, Carter DR (2004) Sutural bone deposition rate and strain magnitude during cranial development. Bone 34, 271-280.
34. Howard TD, Paznekas WA, Green ED, et al. (1997) Mutations in TWIST, a basic helix-loop-helix transcription factor, in Saethre-Chotzen syndrome. Nat Genet 15, 36-41.
35. Ibrahimi OA, Zhang F, Eliseenkova AV, Linhardt RJ, Mohammadi M (2004a) Proline to arginine mutations in FGF receptors 1 and 3 result in Pfeiffer and Muenke cranio-synostosis syndromes through enhancement of FGF binding affinity. Hum Mol Genet 13, 69-78.
36. Ibrahimi OA, Zhang F, Eliseenkova AV, Itoh N, Linhardt RJ, Mohammadi M (2004b) Biochemical analysis of pathogenic ligand-dependent FGFR2 mutations suggests distinct pathophysiological mechanisms for craniofacial and limb abnormalities. Hum Mol Genet 13, 2313-2324.
37. Iseki S, Wilkie AOM, Heath JK, Ishimaru T, Eto K, Morriss-Kay GM (1997) Fgfr2 and osteopontin domains in the developing skull vault are mutually exclusive and can be altered by locally applied FGF2. Development 124, 3375-3384.
38. Iseki S, Wilkie AOM, Morriss-Kay GM (1999) Fqfr1 and Fgfr2 have distinct differentiation- and proliferation-related roles in the developing mouse skull vault. Development 126, 5611-5620.
39. Iseki S, Yoshida T, Ishikawa I, Eto K (2005) Mouse skull vault bones grow by expanding of their primordia and Bmps are involved in this process. J Anat 207, in press.
40. Ishii M, Merrill AE, Chan YS, et al. (2003) Msx2 and Twist cooperatively control the development of the neural crest-derived skeletogenic mesenchyme of the murine skull vault. Development 130, 6131-6142.
41. Itoh N, Ornitz DM (2004) Evolution of the Fgf and Fgfr gene families. Trends Genet 20, 563-569.
42. Jabs EW, Muller U, Li X, et al. (1993) A mutation in the homeodomain of the human MSX2 gene in a family affected with autosomal dominant craniosynostosis. Cell 75, 443-450.
43. Jiang X, Iseki S, Maxson RE, Sucov HM, Morriss-Kay GM (2002) Tissue origins and interactions in the mammalian skull vault. Dev Biol 241, 106-116.
44. Jiang X, Rowitch DH, Soriano P, McMahon AP, Sucov HM (2000) Fate of the mammalian cardiac neural crest. Development 127, 1607-1616.
45. Johnson DE, Williams LT (1993) Structural and functional diversity of the FGF receptor multigene family. Ad Cancer Res 60, 1-41.
46. Johnson D, Iseki I, Wilkie AOM, Morriss-Kay GM (2000) Expression patterns of Twist and Fgfr1-2 and -3 in the developing mouse coronal suture suggest a key role for Twist in suture initiation and biogenesis. Mech Dev 91, 341-345.
47. Kirby ML, Gale TF, Stewart DE (1983) Neural crest cells contribute to aorticopulmonary septation. Science 220, 1059-1061.
48. Krumlauf R (1993) Hox genes and pattern formation in the branchial region of the vertebrate head. Trends Genet 9, 106-112.
49. Lawson KA, Pedersen RA (1992) Clonal analysis of cell fate during gastrulation and early neurulation in the mouse. Ciba Fnd Symp 165, 3-21.
50. Liu Z, Xu J, Colvin JS, Ornitz DJ (2002) Coordination of chondrogenesis and osteogenesis by fibroblast growth factor 18. Genes Dev 16, 859-869.
51. Loeys BL, Chen J, Neptune ER, et al. (2005) A syndrome of altered cardiovascular, craniofacial, neurocognitive and skeletal development caused by mutations in TGFBR1 or Tgfbr2. Nat Genet 37, 275-279.
52. Ma L, Golden S, Wu L, Maxson R (1996) The molecular basis of Boston-type craniosynostosis: the Pro148-His mutation in the N-terminal arm of the MSX2 homeodomain stabilises DNA binding without altering nucleotide sequence preferences. Hum Mol Genet 5, 1915-1920.
53. Mathijssen IMJ, van Splunder J, Vermeij-Keers C, et al. (1999) Tracing craniosynostosis to its developmental stage through bone center displacement. J Craniofac Genet Dev Biol 19, 57-63.
54. Miki T, Bottaro DP, Fleming TP, et al. (1992) Determination of ligand-binding specificity by alternative splicing: two distinct growth factor receptors encoded by a single gene. Proc Natl Acad Sci USA 89, 246-250.
55. Moore KB, Mood K, Daar IO, Moody SA (2004) Morphogenetic movements underlying eye field formation require interactions between the FGF and ephrinB1 signalling pathways. Dev Cell 6, 55-67.
56. Morriss-Kay GM, Tuckett F, Solursh M (1986) The effects of Streptomyces hyaluronidase on tissue organization and cell cycle time in rat embryos. J Embryol Exp Morph 98, 57-70.
57. Muenke M, Schell U, Hehr A, et al. (1994) A common mutation in the fibroblast growth factor receptor 1 gene in Pfeiffer syndrome. Nat Genet 8, 269-274.
58. Neilson KM, Friesel RE (1995) Constitutive activation of fibroblast growth factor receptor-2 by a point mutation associated with Crouzon syndrome. J Biol Chem 270, 26037-26040.
59. Ohbayashi N, Shibayama M, Kurotaki Y, et al. (2002) FGF18 is required for normal cell proliferation and differentiation during osteogenesis and chondrogenesis. Genes Dev 16, 870-879.
60. Oldridge M, McDonald-McGinn DM, Iseki S, et al. (1999) De novo Alu element insertions in FGFR2 identify a distinct pathological basis for Apert syndrome. Am J Hum Genet 64, 446-461.
61. Opperman LA, Adab K, Gakunga PT (2000) Transforming growth factor-beta 2 and TGF-beta 3 regulate fetal rat cranial suture morphogenesis by regulating rates of cell proliferation and apoptosis. Dev Dyn 219, 237-247.
62. Ornitz DM (2001) Regulation of chondrocyte growth and differentiation by fibroblast growth factor receptor 3. Novartis Found Symp 232, 63-76.
63. Ornitz DM, Xu J, Colvin JS, et al. (1996) Receptor specificity of the fibroblast growth factor family. J Biol Chem 271, 15292-15297.
64. Osumi-Yamashita N, Ninomiya Y, Doi H, Eto K (1994) The contribution of both forebrain and midbrain crest cells to the mesenchyme in the frontonasal mass of mouse embryos. Dev Biol 164, 409-419.
65. Osumi-Yamashita N, Ninomiya Y, Eto K (1997) Mammalian craniofacial embryology in vitro. Int J Dev Biol 41, 187-194.
66. Partanen J, Schwartz L, Rossant J (1998) Opposite phenotypes of hypomorphic and Y766 phosphorylation site mutations reveal a function for Fgfr1 in anteroposterior patterning of mouse embryos. Genes Dev 12, 2332-2344.
67. Partanen J, Schwartz L, Rossant J (1998) Opposite phenotypes of hypomorphic and Y766 phosphorylation site mutations reveal a function for Fgfr1 in anteroposterior patterning of mouse embryos. Genes Dev 12, 2332-2344.
68. Poliakov A, Cotrina M, Wilkinson DG (2004) Diverse roles of EPH receptors and ephrins in the regulation of cell migration and tissue assembly. Dev Cell 7, 465-480.
69. Pratt RM, Larsen MA, Johnston MC (11975) Migration of cranial neural crest cells in a cell-free hyaluronate-rich matrix. Dev Biol 44, 298-305.
70. Reardon W, Winter RM, Rutland P, Pulleyn LJ, Jones BM, Malcolm S (1994) Mutations in the fibroblast growth factor receptor 2 gene cause Crouzon syndrome. Nat Genet 14, 174-176.
71. Renier D, Sainte-Rose C, Marchac D, Hirsch JF (1982) Intracranial pressure in craniostenosis. J Neurosurg 57, 370-377.
72. Rice DPC, Åberg T, Chan Y-S, et al. (2000) Integration of FGF and TWIST in calvarial bone and suture development. Development 127, 1845-1855.
73. Robertson SC, Meyer AN, Hart KC, Galvin BD, Webster MK, Donoghue DJ (1998) Activating mutations in the extracellular domain of the fibroblast growth factor receptor 2 function by disruption of the disulphide bond in the third immunoglobulin-like domain. Proc Natl Acad Sci USA 95, 4567-4572.
74. Ruberte E, Wood HB, Morriss-Kay GM (1997) Prorhombomeric subdivision of the mammalian embryonic hindbrain: is it functionally meaningful? Int J Dev Biol 41, 213-222.
75. Rutland P, Pulleyn LJ, Reardon W, et al. (1995) Identical mutations in the FGFR2 gene cause both Pfeiffer and Crouzon syndrome phenotypes. Nat Genet 9, 173-176.
76. Santagati F, Rijli FM (2003) Cranial neural crest and the building of the vertebrate head. Nat Rev Neurosci 4, 806-818.
77. Serbedzija GN, Bronner-Fraser M, Fraser SE (1992) Vital dye analysis of cranial neural crest cell migration in the mouse embryo. Development 116, 297-307.
78. Shishido E, Higashijima S-I, Emory Y, Saigo K (1993) Two FGF-receptor homologues of Drosophila: one is expressed in mesodermal primordium in early embryos. Development 117, 751-761.
79. Soo K, O'Rourke MP, et al. (2002) Twist function is required for the morphogenesis of the cephalic neural tube and the differentiation of the cranial neural crest cells in the mouse embryo. Dev Biol 247, 251-270.
80. Tan S-S, Morriss-Kay GM (1986) Analysis of cranial neural crest cell migration and early fates in postimplantation rat chimaeras. J Embryol Exp Morph 98, 21-58.
81. Thisse B, el Messal M, Perrin-Schmitt F (1987) The twist gene: isolation of a Drosophila zygotic gene necessary for the establishment of dorsoventral pattern. Nucleic Acids Res 15, 3439-3453.
82. Thomas GPL, Wilkie AOMW, Richards PG, Wall SA (2005) FGFR3 P250R mutation increases the risk of reoperation in apparent 'non-syndromic' coronal craniosynostosis. J Craniofac Surg 16, 347-352.
83. Trainor PA, Krumlauf R (2000) Patterning the cranial neural crest: hindbrain segmentation and Hox gene plasticity. Nat Rev Neurosci 1, 116-124.
84. Twigg S, Kan R, Babbs C, et al. (2004) Mutations of ephrin-B1 (EFNB1), a marker of tissue boundary formation, cause craniofrontonasal syndrome. Proc Natl Acad Sci USA 101, 8652-8657.
85. Warren SM, Greenwald JA, Nacamuli RP, et al. (2003a) Regional dura mater differentially regulates osteoblast gene expression. J Craniofac Surg 14, 363-370.
86. Warren SM, Brunet U, Harland RM, Economides AN, Longaker MT (2003b) The BMP antagonist noggin regulates cranial suture fusion. Nature 422, 625-629.
87. Wieland I, Jacubiczka S, Muschke P, et al. (2004) Mutations of the ephrin-B1 gene cause craniofrontonasal syndrome. Am J Hum Genet 74, 1209-1215.
88. Wilkie AOM, Slaney SF, Oldridge M, et al. (1995) Apert syndrome results from localised mutations of FGFR2 and is allelic with Crouzon syndrome. Nat Genet 9, 165-172.
89. Wilkie AOM (1997) Craniosynostosis: genes and mechanisms. Hum Mol Genet 6, 1647-1656.
90. Wilkie AOM (2005) Bad bones, absent smell, selfish testes: the pleiotropic consequences of human FGF receptor mutations. Cytokine Growth Factor Rev 16, 187-203.
91. Wilkinson DG (2001) Multiple roles of EPH receptors and ephrins in neural development. Nat Rev Neurosci 2, 155-164.
92. Xu Q, Mellitzer G, Wilkinson DG (2000) Roles of Eph receptors and ephrins in segmental patterning. Philos Trans R Soc Lond B Bioi Sci 355, 993-1002.
93. Yu K, Herr AB, Waksman G, Ornitz DM (2000) Loss of fibroblast growth factor receptor 2 ligand-binding specificity in Apert syndrome. Proc Natl Acad Sci USA 97, 14536-14541.
94. Yu K, Xu J, Liu Z, et al. (2003) Conditional inactivation of FGF receptor 2 reveals an essential role for FGF signaling in the regulation of osteoblast function and bone growth. Development 130, 3063-3074.
95. Yamagouchi TP, Harpal K, Henkemeyer M, Rossant J (1994) Fgfr-1 is required for embryonic growth and mesodermal patterning during mouse gastrulation. Genes Dev 8, 3032-3044.
96. Zhou YX, Xu X, Chen L, Li C, Brodie SG, Deng CX (2000) A Pro250Arg substitution in mouse Fgfr1 causes increased expression of Cbfa1 and premature fusion of calvarial sutures. Hum Mol Genet 9, 2001-2008.